產(chǎn)品詳情
簡單介紹：
Anti-PCQAP抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-PCQAP抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-PCQAP
Cat. Number:
Anti-PCQAP抗體KL-19915R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded by this gene is a subunit of the multiprotein complexes PC2 and ARC/DRIP and may function as a Anti-PCQAP抗體transcriptional coactivator in RNA polymerase II transcription. This gene contains stretches of trinucleotide repeats and is located in the chromosome 22 region which is deleted in DiGeorge syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Also known as:
Activator recruited cofactor 105 kD; PCQAP / MED15; Activator-recruited cofactor 105 kDa component; ARC105; CAG7A; CTG repeat protein 7a; CTG7A; Mediator complex subunit 15; Mediator of RNA polymerase II transcription subunit 15; PC2 glutamine rich associated protein; PC2 glutamine/Q-rich-associated protein; Positive cofactor 2 glutamine/Q-rich-associated protein; TIG-1; TIG1; TNRC7; TPA inducible Anti-PCQAP抗體gene 1; TPA inducible protein; TPA-inducible gene 1 protein; Trinucleotide repeat containing 7; Trinucleotide repeat containing gene 7 protein. MED15_HUMAN
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated Anti-PCQAP抗體synthetic peptide derived from human PCQAP.
●
Predicted Molecular Weight: 87kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-PCQAP抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-PCQAP抗體
Optimal working dilutions must be determined by the end user.
